Cornea and Laser Eye Institute

The Cornea and Laser Eye Institute (CLEI) is a premier subspecialty center focused on corneal surgery, refractive surgery, and the treatment of keratoconus. Founded by Dr. Peter Hersh, the institute served as the lead center for the clinical trials that led to the first FDA approval of corneal collagen cross-linking in the United States. CLEI integrates advanced clinical care with a robust research program, participating in numerous multicenter trials for innovative ophthalmic technologies and pharmaceuticals. The center is particularly renowned for its 'CLEI Center for Keratoconus,' which offers specialized diagnostics and therapeutic interventions for corneal thinning disorders. Based in Teaneck, New Jersey, the institute bridges the gap between academic research and patient care in the field of ophthalmology.